Ieera Aggarwal

Ieera Aggarwal


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2014 in BMJ Case Reports
Verified
Journal Article
Closed access
IAIeera Aggarwal
Ieera Aggarwal
PTPamela Tan
Pamela Tan
MMManisha Mathur
Manisha Mathur
Spontaneous haemoperitoneum in pregnancy (SHiP) is a rare but serious condition associated with an adverse pregnancy outcome. We present a case of previable twin pregnancy presenting with SHiP secondary to endometriosis, necessitating an emergency laparotomy and hysterotomy as a life-saving measure to achieve haemostasis. At laparotomy there was massive haemoperitoneum with active bleeding from the left fallopian tube and a left salpingectomy was performed. Histological examination showed haemorrhagic foci of endometriosis on the fallopian tube exhibiting florid stromal decidual change. We wish to raise awareness of this uncommon but potentially life-threatening condition requiring early recognition and prompt recourse to surgical intervention to minimise the morbidity and mortality.

8 October 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
GDGayathri Delanerolle
Gayathri Delanerolle
IAIeera Aggarwal
Ieera Aggarwal
Vindya PathirajaVindya Pathiraja
Vindya Pathiraja
George Uchenna ElejeGeorge Uchenna Eleje
George Uchenna Eleje
TTTeck-Hock Toh
Teck-Hock Toh
PPPeter Phiri
Peter Phiri
Background: Menopause affects more than one billion individuals worldwide, yet outcome measurement in research remains narrow, inconsistent, and largely focused on vasomotor and genitourinary symptoms. Existing frameworks do not adequately capture the broader functional and psychosocial impacts reported by patients. We aimed to develop and validate a global Core Patient-Reported Outcome Set for Menopause (cPRO-MARiE) using prospective mixed-methods data from thirteen countries. Methods: We analysed quantitative data from 5,228 participants and qualitative interviews from 302 individuals across thirteen countries spanning diverse socio-cultural and health-system contexts. Validated instruments assessed symptom severity, psychological wellbeing, cognitive function, sleep disturbance, pain and somatic symptoms, and functional outcomes. Qualitative data underwent reflexive thematic analysis guided by the Delanerolle–Phiri framework. A COMET-aligned process integrating quantitative severity patterns, qualitative thematic convergence, cross-country reproducibility, psychometric validation and equity considerations was applied to derive the core outcome set. Findings: Seven domains were consistently identified across all settings: sleep disturbance; psychological wellbeing; cognitive function; pain and somatic symptoms; vasomotor symptoms; genitourinary and sexual health; and social, relational and occupational functioning. These domains demonstrated conceptual stability, cross-country reproducibility and psychometric coherence and were strongly linked to functional impact. The resulting cPRO-MARiE specifies mandatory Tier 1 patient-reported outcomes within each domain, with Tier 2 outcomes retained for context-specific and equity-focused research. Interpretation: cPRO-MARiE is the first empirically derived, globally validated core outcome set for menopause. By capturing symptom domains and functional impacts prioritised by patients across diverse settings, it provides a robust and clinically meaningful framework for outcome measurement in research, routine care, and health-system evaluation.

17 September 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
GDGayathri Delanerolle
Gayathri Delanerolle
JSJie Sun
Jie Sun
JTJulie Taylor
Julie Taylor
PBPaula Briggs
Paula Briggs
LSLucky Saraswat
Lucky Saraswat
PPPeter Phiri
Peter Phiri
Objective Health inequalities during the menopausal transition remain under-explored in UK health services research. Through in-depth qualitative analysis across 50 diverse participant narratives including cis-women and transgender, surgical menopause, minoritised ethnic groups, and rural communities we sought to illuminate the structural, clinical, and sociocultural barriers to equitable menopause care.DesignProspective cross sectional study SettingUrban and rural regions of UKPopulation or SampleMidlife womenMethods We conducted reflexive thematic and content analysis of qualitative interviews from individuals experiencing perimenopause, menopause, and post-menopause across the UK. Participants (n=50) were purposively sampled to maximise diversity in geography, ethnicity, identity, and reproductive history. Data were analysed inductively to identify overarching themes and sub-themes relating to health inequality in menopause, with particular attention to previously underrepresented populations.Results Four intersecting domains of inequity emerged; (1) Clinical care gaps, including delayed diagnosis, misattributed symptoms, lack of surgical menopause protocols, and clinician hesitance around non-HRT pathways; (2) Structural barriers, such as postcode-based access (postcode lottery), service fragmentation, digital exclusion, and reliance on costly private care; (3) Psychosocial and identity-based inequities, including compounded distress among minoritised and transgender participants, cultural silence, reproductive trauma, and under-recognition of intersectional stigma; and (4) Workplace inequalities, marked by absent policies, performance stigma, and premature exit from employment. These findings highlight inequities not previously detailed in UK menopause landscape. Main Outcome MeasuresThemes emerged from the qualitative interviewsConclusions This study uniquely foregrounds lived experiences of menopause-related inequality through an intersectional lens, revealing how clinical, systemic, and occupational structures compound marginalisation. Our insights call for urgent policy and practice reform specifically integrated multidisciplinary pathways, culturally responsive training, standardised HRT access, and menopause-aware workplace policies to advance equitable care across all UK nations.

9 July 2026 in Climacteric
Verified
Journal Article
Closed access
IAIeera Aggarwal
Ieera Aggarwal
VPVindya Pathiraja
Vindya Pathiraja
FHFarah Safdar Husain
Farah Safdar Husain
RARaksha Aiyappan
Raksha Aiyappan
MMManisha Mathur
Manisha Mathur
GDGayathri Delanerolle
Gayathri Delanerolle
Menopause is a universal biological transition, yet in clinical practice presents as a highly variable symptom complex rather than a uniform event [1,2]. Symptom onset, severity, duration, persiste...

8 October 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
GDGayathri Delanerolle
Gayathri Delanerolle
IAIeera Aggarwal
Ieera Aggarwal
Vindya PathirajaVindya Pathiraja
Vindya Pathiraja
George Uchenna ElejeGeorge Uchenna Eleje
George Uchenna Eleje
TTTeck-Hock Toh
Teck-Hock Toh
PPPeter Phiri
Peter Phiri
Background: Menopause is a universal life-course transition that coincides with midlife employment for a growing proportion of the global female workforce. Despite increasing recognition, robust cross-country evidence linking menopausal symptoms to burnout and workforce wellbeing remains limited, particularly outside high-income settings. Methods: This mixed-methods analysis draws on MARIE WP2a, a multi-country cross-sectional cohort of 5,133 participants aged 40–65 years across 13 countries (Brazil, Ghana, India, Sri Lanka, Malaysia, Nigeria, Nepal, Oman, Pakistan, Rwanda, Singapore, Tanzania, and the UK). Quantitative data assessed burnout using the Burnout Assessment Tool (BAT-12) and its subscales (exhaustion, mental distance, cognitive impairment, emotional impairment). Linear mixed-effects models examined associations with employment characteristics, health factors, and menopausal treatments. Qualitative interviews were synthesised with a topics guide using cross-country thematic analysis to contextualise workforce impacts. Results: Overall burnout burden was moderate (mean BAT-12 2.41, SD 0.84), with exhaustion and cognitive impairment most pronounced. Participants early in their current specialty (1–5 years) consistently demonstrated higher burnout and subscale scores than those with ≥21 years’ experience. Disability and long-term conditions were associated with significantly higher burnout across domains. Marked cross-country heterogeneity was observed, reflecting differences in labour structures and social protection. Qualitative findings revealed convergent mechanisms across countries: symptom-driven capacity loss, amplification by inflexible work structures, stigma and non-disclosure, reliance on informal support, policy absence, and financial precarity. Conclusions: Menopause substantially shapes workforce wellbeing across diverse economic and cultural contexts. Symptoms interact with job demands, stigma, and inequitable access to care to drive presenteeism, reduced productivity, and constrained occupational choice. Menopause-informed workplace policies, manager training, low-cost job adjustments, and equitable access to evidence-based care are urgently required to protect women’s health, workforce participation, and productivity in ageing economies.

1 December 2015 in Journal of Gynecologic Surgery
Verified
Journal Article
Closed access
IAIeera Aggarwal
Ieera Aggarwal
MMManish Maheswari
Manish Maheswari
RRRamzi Rajab
Ramzi Rajab
DBDesmond Barton
Desmond Barton
Background: Abdomino-pelvic masses with ascites, peritoneal disease, pleural effusion, and elevated serum CA-125 levels in a patient raises the clinical suspicion of advanced ovarian cancer. However, disseminated tuberculosis and echinococcosis are benign conditions that can mimic an ovarian malignancy. This article presents an unusual case of double benign pathology of an ovarian fibroma and disseminated pelvic hydatid disease that appeared to be advanced ovarian cancer. Case: A 57-year-old postmenopausal woman of Peruvian origin presented with a history of abdominal pain, distension, and chronic cough. On examination, she was noted to be cachectic and had ascites. A chest X-ray showed the presence of pleural effusion. Her serum CA-125 level was elevated. Computed tomography (CT) scans of her thorax, abdomen, and pelvis confirmed the right-sided pleural effusion and revealed the presence of adnexal masses, a calcified parenchymal liver mass, and an omental cake. Initial decision was to start on neoadjuvant chemotherapy in view of the clinical suspicion of advanced ovarian cancer. However, an omental biopsy and a cytologic assessment of her ascitic fluid was negative for cancer. The patient underwent a laparotomy with resection of all macroscopic disease. Histopathology testing showed a left ovarian fibroma. The right ovarian cyst, omental, and other peritoneal nodules all contained hydatid disease. There was no evidence of malignancy. She received albendazole. Results: At her 6-month follow up abdominal ultrasound scan, there was no evidence of disease recurrence and the calcified liver lesion had reduced in size. Conclusions: This highly unusual case highlights the need for histologic and/or cytologic confirmation of malignancy before considering neoadjuvant therapy. With increasing global travel, nonendemic diseases also need to be considered in the differential diagnosis and, thus, eliciting a history regarding foreign travel is important. (J GYNECOL SURG XX:1)